Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2019-05-15 2019-05-15
Drug Identification Number 02425211 02425211
Brand name BIO-EZETIMIBE BIO-EZETIMIBE
Common or Proper name EZETIMIBE EZETIMIBE
Company Name BIOMED PHARMA BIOMED PHARMA
Ingredients EZETIMIBE EZETIMIBE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C10AX C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-05-14 2019-05-14
Estimated end date 2019-06-30 2019-06-30
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments